Solid Biosciences Inc. — Director's Dealing 2019

Jul 30, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2019-07-30

Reporting Person: Koppel Adam (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-07-30	Common Stock	A	1881720	$4.65	Acquired	3871164	Indirect

Footnotes

F1: Represents shares of common stock held directly by BCLS SB Investco, LP ("BCLS").

F2: Bain Capital Life Sciences Investors, LLC, whose managers are Jeffrey Schwartz and Adam Koppel, is the general partner of Bain Capital Life Sciences Partners, LP, which is the general partner of BCLS. As a result, Dr. Koppel may be deemed to share voting and dispositive power with respect to the shares of common stock held by BCLS. Dr. Koppel disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

F3: On July 30, 2019, BCLS purchased 1,881,720 shares of common stock directly from the Issuer at a price per share of $4.65.